Holen Sie sich die Stockscreener-App
4.25
0.00%
0.00
Handel nachbörslich:
4.25
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
What machine learning models say about Sight Sciences Inc.Earnings Miss & High Return Trade Opportunity Guides - Newser
How to use a screener to detect Sight Sciences Inc. breakouts2025 Top Gainers & Daily Profit Maximizing Tips - Newser
Will Sight Sciences Inc. price bounce be sustainableQuarterly Growth Report & Verified Swing Trading Watchlist - Newser
Chart based exit strategy for Sight Sciences Inc.2025 Price Targets & Fast Entry High Yield Stock Tips - Newser
Sight Sciences’ Earnings Call: Balancing Growth and Challenges - MSN
Sight Sciences, Inc. (NASDAQ:SGHT) Q2 2025 Earnings Call Transcript - MSN
Developing predictive dashboards with Sight Sciences Inc. dataVolume Spike & Real-Time Price Movement Reports - Newser
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of “Hold” by Brokerages - Defense World
Real time breakdown of Sight Sciences Inc. stock performance [Market Volume Summary]Daily Profit Maximizing Tips - Newser
Will Sight Sciences Inc. see short term momentumSafe Investment Ideas with Growth Upside - Newser
Is Sight Sciences Inc. Stock a Good Fit for Conservative InvestorsEntry Optimization Guide with Volume Analysis - Newser
Analyzing Sight Sciences Inc. with risk reward ratio chartsFree Community Shared Smart Money Signals - Newser
Sight Sciences, Inc. (NASDAQ:SGHT) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
Sight Sciences (SGHT) Stock Upgraded to 'Buy' with Raised Price Target by Lake Street - AInvest
Sight Sciences (NASDAQ:SGHT) Upgraded at Lake Street Capital - Defense World
Sight Sciences (NASDAQ:SGHT) Raised to Hold at Wall Street Zen - Defense World
Will earnings trigger a reversal in Sight Sciences Inc.Free Conservative Long Term Growth Plans - Newser
Risk adjusted return profile for Sight Sciences Inc. analyzedPrice Action Trading with Volume Confirmation - Newser
Sector Leaders Rotate Capital Into Sight Sciences Inc.Community Shared Smart Money Signals Show Movement - metal.it
Sight Sciences raises 2025 revenue guidance to $72M–$76M amid strong OMNI growth and strategic focus on MIGS leadership - MSN
Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics - MSN
Does Sight Sciences (NASDAQ:SGHT) Have A Healthy Balance Sheet? - simplywall.st
A Quick Look at Today's Ratings for Sight Sciences(SGHT.US), With a Forecast Between $4 to $5 - 富途牛牛
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
Sight Sciences Reports Q2 EPS, Revenue Above Consensus, Glaucoma Ordering Accounts Reach New High - AInvest
Sight Sciences Raises FY25 Revenue Outlook to $72M-$76M, Reiterates Operating Expense Guidance of $101M-$105M. - AInvest
Sight Sciences stock rating upgraded by Lake Street on stabilizing business - Investing.com Australia
Sight Sciences shares surge 17.75% intraday after strong Q2 earnings and upgraded rating by Lake Street analyst. - AInvest
Sight Sciences' Q2 2025: Navigating Contradictions in TearCare Reimbursement and Market Dynamics - AInvest
Sight Sciences Boosts 2025 Revenue Guidance to $72M-$76M on OMNI Growth and MIGS Leadership Focus - AInvest
Earnings call transcript: Sight Sciences Q2 2025 beats revenue expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Sight Sciences Q2 2025 beats revenue expectations - Investing.com India
Sight Sciences August 2025 slides: Targeting growth in $9B eye care market despite Q1 headwinds - Investing.com Australia
Sight Sciences Inc (SGHT) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Sight Sciences 2025 Q2 Earnings Slight Improvement in Losses Amid Revenue Decline - AInvest
Sight Sciences Reports Q2 2025 Financial Results - TipRanks
Sight Sciences Lifts Outlook Despite Revenue Slump - Finimize
Sight Sciences Releases Second Quarter Results and Raises Full-Year Guidance - VisionMonday.com
Sight Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Sight Sciences, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Sight Sciences reports Q2 EPS (23c), consensus (28c) - TipRanks
Sight Sciences: Navigating Revenue Headwinds and Regulatory Challenges to Secure Long-Term Growth - AInvest
Sight Sciences: A Resilient Earnings Beat Signals Undervaluation and Growth in Ophthalmic Innovation - AInvest
Sight Sciences Raises Full-Year Revenue Guidance - TipRanks
Sight Sciences earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance - GlobeNewswire
Sight Sciences Q2 rev. down 8% YoY to $19.6mln, raises FY23 guidance. - AInvest
Sight Sciences Q2 Earnings: Revenue Falls 8%, But Company Raises Full Year Outlook on Strong Glaucoma Growth - Stock Titan
SAHARA trial demonstrates sustained TearCare benefits for evaporative DED - Ophthalmology Times
Sight Sciences releases cost-utility analysis comparing TearCare and cyclosporine 0.05% in dry eye - Optometry Times
Strategies to average down on Sight Sciences Inc.Day Trading Setup Forecast with Trend Model - Newser
2.30%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):